TELA Bio (TELA) Depreciation & Amortization (CF) (2018 - 2026)
TELA Bio (TELA) recorded quarterly Depreciation & Amortization (CF) of $169000.0 in Q1 2026, up 30.0% quarter-over-quarter from $130000.0 in Q4 2025, and down 1.74% on a YoY basis from $172000.0 in Q1 2025.
TELA Bio (TELA) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
TELA Bio's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $169000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 1.74% year-over-year to $169000.0; the TTM figure through Mar 2026 stood at $627000.0 (down 0.95% YoY), while the FY2025 annual figure was $630000.0, up 5.0% from the prior year.
- Depreciation & Amortization (CF) was $169000.0 for Q1 2026 at TELA Bio, up from $130000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $175000.0 in Q2 2025 to a low of $38000.0 in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $128352.9 across 5 years, with a median of $130000.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) slumped 66.07% in 2023, then jumped 265.79% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $112000.0 in 2022, then plunged by 66.07% to $38000.0 in 2023, then surged by 265.79% to $139000.0 in 2024, then retreated by 6.47% to $130000.0 in 2025, then rose by 30.0% to $169000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $169000.0 (Q1 2026), $130000.0 (Q4 2025), and $153000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | TELA Bio | 48.23 Mn | 8.69 Mn | 12.52 Mn | 169,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,000.00 |
| Mar 31, 2026 | 169,000.00 |
| Dec 31, 2025 | 130,000.00 |
| Dec 31, 2025 | 130,000.00 |
| Sep 30, 2025 | 153,000.00 |
| Sep 30, 2025 | 153,000.00 |
| Jun 30, 2025 | 175,000.00 |
| Jun 30, 2025 | 175,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 139,000.00 |
| Dec 31, 2024 | 139,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | 154,000.00 |
| Jun 30, 2024 | 154,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Dec 31, 2023 | 38,000.00 |